PharmaForce

PharmaForce PharmaForce is a Third Party Administrator that supports your Contract Pharmacy, Mixed Use/Split Bill

PharmaForce provides the most advanced solutions to help our clients navigate and execute their 340B programs. PharmaForce 340B solutions were created to improve the overall 340B program ex*****on and benefits for Covered Entities, Pharmacies, and Patients. Our mission is to continuously provide reliable and flexible technology, improve customer service, and drive down the administrative fees needed to support the 340B programs.

Referral eligibility remains one of the more nuanced areas of 340B compliance. HRSA's patient definition guidance does n...
09/04/2026

Referral eligibility remains one of the more nuanced areas of 340B compliance.

HRSA's patient definition guidance does not provide a separate, prescriptive test specifically for referrals. Instead, covered entities must be able to demonstrate that an individual meets 340B patient eligibility requirements, including maintaining appropriate health records and, when care is provided through a referral or other arrangement, that responsibility for the patient's care remains with the covered entity.

That makes clear, consistent documentation critical.

Referrals+ by PharmaForce helps covered entities strengthen that process with:
- Structured tracking of referral relationships and supporting documentation
- Visibility into referral claims and the documentation supporting eligibility
- Streamlined workflows that help staff identify and manage eligible referrals
- Reporting and records designed to support compliance and audit readiness

Referral capture can help covered entities identify additional compliant 340B opportunities while maintaining the documentation and controls needed to support program integrity.

Schedule a Demo: https://hubs.la/Q04wH80q0

For Lynn Eschenbacher, Chief Pharmacy & Strategy Officer at PharmaForce, the purpose behind 340B is simple:“Our job isn'...
09/01/2026

For Lynn Eschenbacher, Chief Pharmacy & Strategy Officer at PharmaForce, the purpose behind 340B is simple:
“Our job isn't just to manage a program. It's to make sure every dollar of savings actually reaches those who need it.”

That perspective shapes how we think about 340B technology at PharmaForce.

It’s not just about checking compliance boxes or generating another report. It’s about giving 340B teams better visibility, stronger tools, and more confidence in their day-to-day operations so they can protect the savings their organizations and patients depend on.

Because at the end of the day, better technology should lead to better outcomes.

📅 Want to see that approach in action? Schedule a demo with our team.
link: https://hubs.la/Q04w1wSv0

What if the Rebate Model didn’t have to mean more manual work for your team?With PharmaForce, your team can manage the r...
08/27/2026

What if the Rebate Model didn’t have to mean more manual work for your team?

With PharmaForce, your team can manage the rebate process in one place:
• Automate rebate claim submission instead of adding another manual process to your team’s workload
• See rejection reasons directly in the platform so you know what happened and what needs attention
• Track every claim from submission through payment without piecing together updates across systems
• Reconcile rebate payments so you can see what you were expecting versus what you actually received
• Quickly identify claims that need action
• Keep a complete record of your rebate activity for reporting, follow-up, and audit needs

See what PharmaForce has built and how it could work for your organization.

Find out more and schedule time with our team to see our solution in action: https://hubs.la/Q04vzVz50

340B contract pharmacy requirements are evolving fast.PharmaForce gives covered entities the claim visibility and report...
08/25/2026

340B contract pharmacy requirements are evolving fast.

PharmaForce gives covered entities the claim visibility and reporting they need to stay ahead.

Learn more: https://hubs.la/Q04vcPBK0

HRSA Advances a Revised 340B Rebate Model Pilot — While Manufacturer Data Demands Move Ahead RegardlessWhile HRSA's 340B...
08/12/2026

HRSA Advances a Revised 340B Rebate Model Pilot — While Manufacturer Data Demands Move Ahead Regardless
While HRSA's 340B Rebate Model Pilot remains stalled in federal court, several manufacturers have moved ahead on their own. Eli Lilly and Novo Nordisk now require covered entities to submit claim-level data for in-house 340B dispensing, not just contract pharmacy claims, with both policies fully in effect since April 2026. At least seven manufacturers have introduced similar requirements, and some covered entities have already lost 340B pricing access after missing a submission window.

This means claim-level reporting is no longer a contract pharmacy issue. It now touches every dispensing channel a covered entity operates.

ClaimsConnect by PharmaForce helps covered entities keep pace with this shift:
✔ Real-time visibility into submission status by manufacturer
✔ Built-in reconciliation to catch missed windows before pricing is denied
✔ Audit-ready documentation if a dispute or ADR filing becomes necessary

Manufacturer requirements are changing by the month. Your reporting infrastructure should not be the reason savings are lost.

📅 Schedule a Demo: https://hubs.la/Q04sMfw-0

HRSA reported adverse findings in 66% of its FY2024 audits, and every entity audited had a TPA in place beforehand.Most ...
08/07/2026

HRSA reported adverse findings in 66% of its FY2024 audits, and every entity audited had a TPA in place beforehand.

Most covered entities have never faced a real audit, but that will all change as oversight intensifies across federal, state, and manufacturer channels.

Our new guide, "The Real Cost of 340B Audit Exposure in a Shifting Landscape," calculates what a single adverse finding actually costs a mid-size DSH hospital, and maps the regulatory pressure now driving that cost higher.

📖 Read it here: https://hubs.la/Q04sfbBD0.

The 340B Rebate Model is moving forward — and covered entities now have a firm date to plan around: January 1, 2027.For ...
08/06/2026

The 340B Rebate Model is moving forward — and covered entities now have a firm date to plan around: January 1, 2027.
For pharmacy operations, compliance, and finance leaders, the questions are no longer hypothetical. What has actually changed under the revised model? What should your organization be doing this quarter, not next year?
Join PharmaForce's pharmacy and regulatory experts for an executive briefing covering:
→ The latest updates from HRSA and what they mean for covered entities
→ Key implementation dates and milestones to track
→ Operational and compliance considerations as the model takes shape
→ The questions we're hearing most from 340B leaders nationwide → Practical steps you can start evaluating today
Space is limited — reserve your seat now.
https://hubs.la/Q04s7cMX0

In the past few months, the Senate and House have both seen 340B reform proposals.🔷 Senate: Cassidy's 340B Drug Pricing ...
08/04/2026

In the past few months, the Senate and House have both seen 340B reform proposals.

🔷 Senate: Cassidy's 340B Drug Pricing Integrity and Affordability for Patients Act
🔷 House: Bipartisan SECURE 340B Act

Neither has become law yet, but both point in a consistent direction.

Check out our blog to find out what these proposals could mean for covered entities.

📖 Read here: https://hubs.la/Q04rShpQ0

It's official. The 340B Rebate Model now has a January 1, 2027 implementation date.After months of uncertainty, HRSA has...
07/31/2026

It's official. The 340B Rebate Model now has a January 1, 2027 implementation date.

After months of uncertainty, HRSA has announced the Rebate Model is moving forward, and for covered entities, the planning window just got a lot shorter.

If you're responsible for your organization's 340B program, now is the time to understand:
• What changed
• What it means for your operations
• Where the biggest financial and compliance risks are
• What you should be doing before January

We've broken it all down in our latest article.
Read the blog: https://hubs.la/Q04rxJsW0

Already thinking about how you'll manage rebate submissions, reconciliation, and reporting? See how PharmaForce is helping covered entities prepare today.

Explore our solution & schedule a conversation with one of our 340B experts: https://hubs.la/Q04rwXBY0

Day one at the 340B Coalition Summer Conference is in the books, and the energy has been incredible.From nonstop convers...
07/14/2026

Day one at the 340B Coalition Summer Conference is in the books, and the energy has been incredible.

From nonstop conversations at our booth, to connecting with so many innovative 340B leaders, it's been a day full of fresh ideas, new relationships, and meaningful discussions about the future of 340B.

One of today's highlights was hosting a luncheon with our partners at Cencora. Together, we had an engaging conversation about the power of partnership, integrations, and what it takes to help covered entities succeed in today's rapidly evolving 340B landscape.

We can't wait for more conversations, demos, and opportunities to connect over the next two days!

If you're at Coalition, stop by Booth 517 to meet the PharmaForce team, see Command Center in action, and chat with us about what's next for 340B.

See you tomorrow!

Address

985 Old Eagle School Road
Wayne, PA
19087

Alerts

Be the first to know and let us send you an email when PharmaForce posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to PharmaForce:

Shortcuts

Share